BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis. - sprookjes - yvandenbroek - TriplyDB

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

http://www.wikidata.org/entity/Q33983338

about

Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci New therapies for pneumococcal meningitis.Investigational new drugs for the treatment of resistant pneumococcal infections.Treatment strategies for central nervous system infections.Emerging drugs for acute bacterial meningitis.Acute bacterial meningitis in infants and children: epidemiology and management.

P2860

Q34719869-56C5CCE9-C0D0-4C41-B877-E426E6CEEC60 Q35005511-6EB85552-3B91-4097-84B2-C67B637A2FB0 Q35753477-1269D515-A907-4D2C-BBA1-23B61B4522C8 Q36210902-AA9D8856-91A5-4978-A260-2F62F9A750A4 Q37483938-1229E4F2-C203-494B-8614-517E10C9A080 Q37558543-0FC6F713-1FB0-4941-A7ED-D414A1DD3309 Q37945754-73489673-B055-4FDA-B7F8-8877DA9C1BB1

P2860

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

http://www.wikidata.org/entity/Q33983338

description

2001 nî lūn-bûn

@nan

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

@ast

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

@en

type

label

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

@ast

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

@en

prefLabel

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

@ast

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

@en

P1433

Q33983338-81384857-0914-4552-873B-C49EB81A7304

P1476

Q33983338-F0F54C58-2F78-4EF4-B1A0-DB9A4E8F11CB

P2093

Q33983338-13E0765A-BC21-40F3-89FE-82F88E8CD65A

Q33983338-20D8F59D-90EC-4EF7-9275-3BA0C705E8A4

Q33983338-4223CB8D-9BF2-4327-91F6-C47B4F13BC41

Q33983338-428CCBF7-E073-4517-BF1F-6530F8CB4358

Q33983338-6F8AC386-ABFE-4586-9C2A-0E714039EC18

Q33983338-9B29426D-2BCA-4F45-B96D-EF3DC396E6C6

Q33983338-DB73D2F5-6687-4F60-854D-C2727ED00597

Q33983338-E5951FC8-DFF2-4FD9-A94E-2FAD828586BE

P2860

Q33983338-204F0946-0CBA-42BE-8827-D589FD78F6DA

Q33983338-2A8CD9C1-7340-4EB7-9575-F009859887BE

Q33983338-2AE03A97-CF79-40AD-A48F-9E8A97303767

Q33983338-2F996556-B585-4415-9962-8497ECEAB5AA

Q33983338-698D62CB-C420-4C35-9801-B8752B885F9E

Q33983338-6A0232B2-DD4F-47D7-A657-3EDBEAB0F20C

Q33983338-6F3B2A09-2604-4EE8-A7D9-B1CA773E9F19

Q33983338-7F39AA0E-B76B-4E33-9473-80B5FF1A1375

Q33983338-80871BFA-FE13-4038-9EBC-15C9376C3C8A

Q33983338-9779B106-810A-4BFC-AAA6-7C517E61BFBD

P304

Q33983338-D35851F0-49C7-4DA2-9E5C-34AAA1292CF8

P31

Q33983338-5FB53626-1005-4EB4-A4B1-1E5FFB1AAEFB

P356

Q33983338-7AF65C62-792F-4A4C-AF3B-1E3672E15E0C

P407

Q33983338-633B2337-BE42-4088-BFF3-8EB19CEFA1FB

P433

Q33983338-82E82C05-AFA9-48B8-8EF3-2E9CA085D0E0

P478

Q33983338-5502BE6A-425B-4AA7-916A-06444CA170B4

P577

Q33983338-79C5168B-DCF8-4DA1-9BD6-3A5E8F4941F3

P5875

Q33983338-4E36800C-D107-47AF-A16B-3940E0ABEA2B

P698

Q33983338-1E267E51-05D7-407D-95A8-A63446847BC3

P921

Q33983338-4F2807BA-3695-4D38-BF55-F2EA72F29E9C

P932

Q33983338-72CD9AFF-D0D5-4BA7-BB67-00960D9DEC7E

P356

AAC.45.11.3098-3103.2001

P1433

Antimicrobial Agents and Chemotherapy

P1476

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

@en

P2093

F Ghaffar

http://www.w3.org/2001/XMLSchema#string

G H McCracken

http://www.w3.org/2001/XMLSchema#string

I C Michelow

http://www.w3.org/2001/XMLSchema#string

J Iglehart

http://www.w3.org/2001/XMLSchema#string

J Saavedra

http://www.w3.org/2001/XMLSchema#string

K Olsen

http://www.w3.org/2001/XMLSchema#string

R D Hardy

http://www.w3.org/2001/XMLSchema#string

V Rodriguez-Cerrato

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756

Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.

Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis

Bacterial meningitis in the United States in 1995. Active Surveillance Team.

Inhibition of penicillin transport from the cerebrospinal fluid after intracisternal inoculation of bacteria.

Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Microbioassay of antimicrobial agents

Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model

P304

3098-3103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.45.11.3098-3103.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11750735

http://www.w3.org/2001/XMLSchema#string

P698

11600362

http://www.w3.org/2001/XMLSchema#string

P921

P932

90788

http://www.w3.org/2001/XMLSchema#string